A detailed history of Bruce G. Allen Investments, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 12 shares of HAE stock, worth $880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 10 20.0%
Holding current value
$880
Previous $804,000 16.54%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

BUY
$71.16 - $93.38 $142 - $186
2 Added 20.0%
12 $937,000
Q3 2024

Oct 08, 2024

BUY
$72.45 - $91.58 $724 - $915
10 New
10 $804,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.76B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.